Ischemia: Clinical Trials

4 trials for Ischemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 14Unknown 4

Follow Ischemia: new trials by email Literature Review of Ischemia trials Research Report on Ischemia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion
Cerebrolysin - Basilar Artery Occlusion, Posterior Circulation Brain Infarction
Early Phase 1UnknownUniversity Hospital Sestre Milosrdnice202024-07-012024-07-09
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
[89Zr]Zr-DFO-APAC, PET/CT scan - Peripheral Arterial Occlusive Disease, Critical Limb Ischemia
Early Phase 1UnknownAplagon Oy102024-02-012025-01-30
Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy
UCA-PSCs/bFGF or bFGF Intramuscular injection - Critical Limb Ischemia
Early Phase 1UnknownNanjing University402023-06-302023-12-18
68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction
68Ga-BNOTA-PRGD2 - Coronary Artery Disease
Early Phase 1UnknownPeking Union Medical College Hospital502012-02-012017-04-07

Narrower conditions

Chronic Limb-Threatening Ischemia (2)  ·  Brain Infarction (1)  ·  Coronary Artery Disease (1)  ·  Myocardial Infarction (1)  ·  Peripheral Arterial Occlusive Disease 1 (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Vascular Diseases (4)  ·  Arterial Occlusive Diseases (3)  ·  Arteriosclerosis (3)  ·  Atherosclerosis (2)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Infarction (2)  ·  Necrosis (2)  ·  Peripheral Arterial Disease (2)  ·  Peripheral Vascular Diseases (2)  ·  Brain Diseases (1)

Interventions

68gallium-BNOTA-PRGD2 (1)  ·  cerebrolysin (1)

Sponsors

Aplagon Oy (1)  ·  Nanjing University (1)  ·  Peking Union Medical College Hospital (1)  ·  University Hospital Sestre Milosrdnice (1)

Countries

China (2)  ·  Netherlands (1)

Top investigators

Haiming Xia, phD (1)  ·  Schelto Kruijff, MD, Prof (1)  ·  Zhaohui Zhu, MD (1)

NIH funding

2023 (1)